Jaime Landman, MD, FRCS
Dr. Landman is the chair of the Department of Urology at UC Irvine. He possesses extensive clinical expertise in endoscopic and laparoscopic kidney surgery, and his research has provided patients with more precise treatment.
Dr. Landman is considered an international expert in the management of kidney cancer and is a pioneer on the application of minimally invasive techniques for ablation of kidney cancer. Additionally, he has helped to re-define the diagnosis of kidney cancer through the development of novel diagnostic biopsy techniques.
Dr. Landman developed and tested ablation devices that are now used for minimally invasive ablation of renal tumors and malignancies. His research allowed him to pioneer the combined antegrade and retrograde approach for treatment of complex kidney stones. He is actively working on tumor markers for urologic cancers and the relationship between kidney cancer and surrounding tissues.
Biography
Dr. Landman directs the course on management of small renal tumors at the annual meeting of the American Urological Association, as well as the small renal mass mini-fellowship at UC Irvine. He is respected as an international expert in the management of kidney cancer.
Roles & Memberships
Dr. Ahlering is a member of the editorial boards of the journals: Urology, and the Journal of Urology, and the Societies of the American Urological Association, and its Wester Section Treasurer. He was an invited speaker at Senator Barbara Boxer’s Prostate Cancer Forum in 1996 and has lectured at the American Cancer Society’s Prostate Cancer Awareness Forum in Southern California. He became a member of the Society of Urologic Oncology in 1998.